NEJM (@NEJM) header
NEJM (@NEJM) profile picture

The New England Journal of Medicine is the world’s leading medical journal and website.

Boston, MA
Joined March 2009
Photo by NEJM (@NEJM)Photo by NEJM (@NEJM)Photo by NEJM (@NEJM)Photo by NEJM (@NEJM)Photo by NEJM (@NEJM)Photo by NEJM (@NEJM)Photo by NEJM (@NEJM)Photo by NEJM (@NEJM)Photo by NEJM (@NEJM)Photo by NEJM (@NEJM)
Pinned Tweet
𝘏. 𝘱𝘺𝘭𝘰𝘳𝘪 infection is an infectious disease, and treatment regimens should ideally be guided by antimicrobial-susceptibility testing whenever possible. 🔗 nej.md/4Bj3O58 Both phenotypic (culture-based) and molecular methods of antimicrobial-susceptibility testing are available (seen in figure). Culture-based testing remains the reference standard because it is the only method that can ascertain the susceptibility of isolates to all antibiotics commonly used for eradication. Molecular antimicrobial-susceptibility testing offers greater efficiency than culture-based testing by eliminating the need for 𝘏. 𝘱𝘺𝘭𝘰𝘳𝘪 culture. Molecular-based testing can be conducted with fresh or formalin-fixed gastric-tissue samples (used for histopathological examination) and successfully cultured isolates. More recently, gastric-fluid samples obtained from a swallowed gastric string have emerged as a cost-effective alternative culture-based testing method. Stool-based molecular antimicrobial-susceptibility testing is now available, which avoids invasive endoscopy. Commercial polymerase-chain-reaction–based kits are now available for identifying 𝘏. 𝘱𝘺𝘭𝘰𝘳𝘪 resistance to clarithromycin and levofloxacin by detecting specific mutations in the 𝘏. 𝘱𝘺𝘭𝘰𝘳𝘪 23S ribosomal RNA and gyrA genes, respectively. A meta-analysis reported high accuracy of these molecular methods for detecting antibiotic resistance in gastric-biopsy samples, with sensitivity and specificity of 96% and 96%, respectively, for clarithromycin resistance and 97% and 99% for quinolone resistance. Learn more in the Review Article “𝘏𝘦𝘭𝘪𝘤𝘰𝘣𝘢𝘤𝘵𝘦𝘳 𝘱𝘺𝘭𝘰𝘳𝘪 Infection — Advances, Challenges, and the Road Ahead” by Hong Li, MD, PhD, Francis Megraud, MD, and Barry J. Marshall, MD: nej.md/4Bj3O58
8
175
2
592
43,664
A 33-year-old butcher presented with painful ulcers on the left hand and several hours of worsening left arm swelling. Twenty-four hours later, the lesions progressed to large hemorrhagic bullae. Read the full case details in the Images in Clinical Medicine article “Cutaneous Anthrax”: nej.md/4t50hnB
2
5
1
28
7,497
In a new Perspective, Emma E. McGinty, PhD, argues that shifting federal priorities are threatening to curtail research on important health-related policy issues, in keeping with a movement to distance scientists from policymaking. Read the full Perspective: nej.md/4kW84BU
4,159
ARDS is marked by noncardiogenic pulmonary edema and hypoxemia. Management includes treatment of the underlying cause and avoidance of ventilator-induced lung injury and fluid overload. Prone positioning and ECMO can also be useful. Read the Review Article “Acute Respiratory Distress Syndrome” by Carolyn S. Calfee, MD, and Daniel F. McAuley, MD: nej.md/4t69Vq0
1
47
3
215
11,264
Correspondence: Autoantibodies against Type I Interferons and Death from H7N7 Avian Influenza nej.md/4iJ84CN #Genetics #InfectiousDisease
1
2
11
5,474
Out now: The December 2026 issue explores primary care, specialty care, hip surgery, patient-reported outcome measures, medication safety, ambient AI, resident and fellow mental health, health-related social needs, patient experience, and rare diseases: nej.md/4iWAvNH
1
7
1
7
3,126
Perspective essay by Ellen M. Einterz, MD: Early Days, Late Nights nej.md/4iJA3lx #HealthPolicy #MedEd
5
4,604
In the conclusion to his illustrated story about his experiences in India, Dr. Ryan Montoya contemplates how he can meaningfully contribute to the lives of the people in this Bengaluru village. Read “Chapter 2, Issue 2: Annual Review” in NEJM Voices and sign up for email alerts: nej.md/4eJSFAY
2
4
5,657
An interim analysis of a phase 3 randomized trial involving adults with IgA nephropathy showed that ravulizumab, a terminal complement inhibitor, led to a significantly greater reduction in proteinuria than placebo. Full I CAN trial results and Research Summary: nej.md/4iwTFdS
3
4
34
7,141
Perspective by Divya Mallampati, MD, MPH, Chase Binion, PhD, and Neeta L. Vora, MD: Equity in Maternal–Fetal Medicine — Technological Advances and a Potential Path Forward nej.md/4AjlYCz #MedicalEthics #MedicalPractice
1
1
2
4,811
NEJM retweeted
In the latest episode of the AI Grand Rounds podcast, @munjalshah, co-founder and CEO of @hippocraticai, believes voice-based clinical agents may help health systems reach patients who otherwise fall through the cracks. Listen to the full episode nejm.ai/ep48
4
5
9
3,380
Images in Clinical Medicine: Lung Hernia with a Chest-Wall Bulge nej.md/4iGMi2l #Surgery #Pulmonology
2
10
6,424
Subacute sclerosing panencephalitis (SSPE), a progressive neurodegenerative disorder that eventually leads to death, can occur years after measles infection. @NEJMClinician Editor-in-Chief @PaulSaxMD explains why physicians should mention the devastating effects of SSPE when counseling parents about vaccination. See what else matters this week at clinician.nejm.org.
6
17
5
60
11,387
Looking closely at your patients can uncover information they haven’t yet, or can’t, put into words, writes @MKittlesonMD in a new NEJM Voices blog post. Read the post and sign up for email alerts: nej.md/3XaplgU
4
1
13
7,621
A new review examines current tools and recent advancements in malaria control and prevention. Read the full review: nej.md/4sQ0qLg
1
7
25
9,711
NEJM retweeted
The authors analyze the degree to which clinical specialties are shielded from, or threatened by, AI depending on how much of their work requires in-person physical interaction. Learn more: nejm.ai/3UDkrIv
166
423
268
1,290
975,501
Patients arrive carrying information they haven’t yet, or can’t, put into words. Before the history, before the exam, before the first question, look carefully. The story is already in the room. The Power of Observation voices.nejm.org/doi/full/10.… @NEJM
3
10
1
37
6,295
Among patients with acute coronary syndromes undergoing percutaneous coronary intervention, the risk of ischemic events was not lower with a default prasugrel policy than with a default ticagrelor policy. Full SWITCH-SWEDEHEART trial results and Research Summary: nej.md/4wGVCZd #ESCCongress
5
31
106
15,368
How should clinicians respond when parents express fears related to vaccinating their children? 2025–26 NEJM Editorial Fellow Katerina Lin, MD, shares practical approaches to childhood vaccine hesitancy. Go deeper on this subject: nej.md/3Riw19N
8
26
3
78
12,502
Original Article: Semaglutide for the Treatment of Obesity in Children 6 to <12 Years of Age (phase 3 STEP Young trial) nej.md/4ArUURG #ObesityWeek #OW2026 | @ObesityWeek
7
29
2
121
19,667
Images in Clinical Medicine: Lung Hernia with a Chest-Wall Hematoma nej.md/4k9ru6a #EmergencyMedicine #Radiology
1
6
1
22
12,277